Overview
Chih-kai Hsu practices practicing medicine in Taoyuan, Taiwan.
Their clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Pneumocystis Jiroveci Pneumonia, and Schwannoma.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chih-kai Hsu
Is Chih-kai Hsu a top-rated expert for Neurofibromatosis Type 1 (NF1)?
MediFind is an objective health platform that identifies experts based on real-world data. Chih-kai Hsu is classified as an Experienced expert for Neurofibromatosis Type 1 (NF1), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chih-kai Hsu participate in research or clinical trials?
Yes. Chih-kai Hsu has published 15 articles and abstracts on conditions like Neurofibromatosis Type 1 (NF1). You can view a list of Chih-kai Hsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- NeurofibromatosisHsu isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)
- Pneumocystis Jiroveci Pneumonia
- SchwannomaHsu isExperienced. Learn about Schwannoma.